MINI FUTURE LONG - SMITH & NEPHEW | Real-time Bid/Ask 09:43:37 22/05/2024 BST | ||
| 2.04 EUR / 2.06 EUR | +1.49% |
|
| Current month | +28.66% | ||
| 1 month | +40.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 21/05/24 | 2.02 | -6.91% |
| 20/05/24 | 2.17 | +3.33% |
| 17/05/24 | 2.1 | +2.44% |
| 16/05/24 | 2.05 | -0.49% |
| 15/05/24 | 2.06 | -2.37% |
Delayed Quote Börse Stuttgart
Last update May 21, 2024 at 02:33 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG1DZG |
| ISIN | DE000MG1DZG3 |
| Date issued | 03/04/2024 |
| Strike | 845 p |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 1.81 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.17 € |
|---|---|
| Lowest since issue | 1.32 € |
| Spread | 0.02 € |
| Spread % | 0.97% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.96
USD
Average target price
16.36
USD
Spread / Average Target
+26.20%
- Stock Market
- Certificates
- Certificat
